Browsing by Author Palacios, Rosario

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 18 of 18
PreviewTitleAuthor(s)Issue Date
A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection CureCorma-Gómez, Anaïs; Macías, Juan; Rivero, Antonio; Rivero-Juarez, Antonio; de Los Santos, Ignacio; Reus-Bañuls, Sergio; Morano, Luis; Merino, Dolores; Palacios, Rosario; Galera, Carlos; Fernández-Fuertes, Marta; González-Serna, Alejandro; de Rojas, Itziar; Ruiz, Agustín; Sáez, María E.; Real, Luis M.; Pineda, Juan A.20-Aug-2021
A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.Corma-Gómez, Anaïs; Macías, Juan; Rivero, Antonio; Rivero-Juarez, Antonio; de Los Santos, Ignacio; Reus-Bañuls, Sergio; Morano, Luis; Merino, Dolores; Palacios, Rosario; Galera, Carlos; Fernández-Fuertes, Marta; González-Serna, Alejandro; de Rojas, Itziar; Ruiz, Agustín; Sáez, María E; Real, Luis M; Pineda, Juan A20-Aug-2021
All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010.Hernando, Victoria; Alejos, Belén; Monge, Susana; Berenguer, Juan; Anta, Lourdes; Vinuesa, David; Palacios, Rosario; Muga, Roberto; Moreno, Santiago; Jarrin, InmaAug-2013
Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers.Benito, José M; Ortiz, María C; León, Agathe; Sarabia, Luis A; Ligos, José M; Montoya, María; Garcia, Marcial; Ruiz-Mateos, Ezequiel; Palacios, Rosario; Cabello, Alfonso; Restrepo, Clara; Rodriguez, Carmen; Del Romero, Jorge; Leal, Manuel; Muñoz-Fernández, María A; Alcamí, José; García, Felipe; Górgolas, Miguel; Rallón, Norma; ECRIS integrated in the Spanish AIDS Research Network28-Feb-2018
Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.Rivero, Antonio; Pérez-Molina, José Antonio; Blasco, Antonio Javier; Arribas, José Ramón; Crespo, Manuel; Domingo, Pere; Estrada, Vicente; Iribarren, José Antonio; Knobel, Hernando; Lázaro, Pablo; López-Aldeguer, José; Lozano, Fernando; Moreno, Santiago; Palacios, Rosario; Pineda, Juan Antonio; Pulido, Federico; Rubio, Rafael; de la Torre, Javier; Tuset, Montserrat; Gatell, Josep M25-Jul-2016
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 TrialPulido, Federico; Ribera, Esteban; Lagarde, Maria; Perez-Valero, Ignacio; Palacios, Rosario; Iribarren, Jose A.; Payeras, Antoni; Domingo, Pere; Sanz, Jose; Cervero, Miguel; Curran, Adrian; Rodriguez-Gomez, Francisco J.; Tellez, Maria J.; Ryan, Pablo; Barrufet, Pilar; Knobel, Hernando; Rivero, Antonio; Alejos, Belen; Yllescas, Maria; Arribas, Jose R.; DUAL-GESIDA-8014-RIS-EST45 Study G15-Dec-2017
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial.Pulido, Federico; Ribera, Esteban; Lagarde, María; Pérez-Valero, Ignacio; Palacios, Rosario; Iribarren, José A; Payeras, Antoni; Domingo, Pere; Sanz, José; Cervero, Miguel; Curran, Adrián; Rodríguez-Gómez, Francisco J; Téllez, María J; Ryan, Pablo; Barrufet, Pilar; Knobel, Hernando; Rivero, Antonio; Alejos, Belén; Yllescas, María; Arribas, José R; DUAL-GESIDA-8014-RIS-EST45 Study Group2017
Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naïve patients in southern Spain.González-Domenech, Carmen M; Viciana, Isabel; Delaye, Luis; Mayorga, María Luisa; Palacios, Rosario; de la Torre, Javier; Jarilla, Francisco; Castaño, Manuel; Del Arco, Alfonso; Clavijo, Encarnación; Santos, Jesús8-Jan-2018
Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR.Frías, Mario; Rivero-Juárez, Antonio; Téllez, Francisco; Palacios, Rosario; Jiménez-Arranz, Álvaro; Pineda, Juan A; Merino, Dolores; Gómez-Vidal, María Amparo; Pérez-Camacho, Inés; Camacho, Ángela; Rivero, Antonio29-Aug-2019
Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera®). Efficacy and safety analysis. GeSida Study 8114.Pérez-Hernández, Isabel A; Palacios, Rosario; Mayorga, Marisa; González-Doménech, Carmen M; Castaño, Manuel; Rivero, Antonio; Arco, Alfonso del; Lozano, Fernando; Santos, Jesús2-Nov-2014
Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study.Domingo, Pere; Suarez-Lozano, Ignacio; Gutierrez, Félix; Estrada, Vicente; Knobel, Hernando; Palacios, Rosario; Antela, Antonio; Blanco, José-Ramón; Fulladosa, Xavier; VACH24-Apr-2019
Progression to hepatitis C virus micro-elimination in people living with HIV in Spain.Rivero-Juarez, Antonio; Tellez, Francisco; Mayorga, Maria Isabel; Merino, Dolores; Espinosa, Nuria; Macias, Juan; Palacios, Rosario; Paniagua, María; Collado, Antonio; Mohamed, Omar; Perez-Stachowski, Javier; Hernandez-Quero, Jose; Fernandez-Fuertes, Elisa; Rivero, Antonio; Grupo de estudio de Hepatitis virales (HEPAVIR) of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI)31-Oct-2020
Relevant gender differences in epidemiological profile, exposure to first antiretroviral regimen and survival in the Spanish AIDS Research Network Cohort.Pérez-Elías, María Jesús; Muriel, Alfonso; Moreno, Ana; Martínez-Colubi, María; Iribarren, José A; Masiá, Mar; Blanco, José R; Palacios, Rosario; Romero, Jorge del; Pérez, Desire G; Hernando, VictoriaSep-2014
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV.Corma-Gómez, Anaïs; Fernández-Fuertes, Marta; García, Estefanía; Fuentes-López, Ana; Gómez-Ayerbe, Cristina; Rivero-Juárez, Antonio; Domínguez, Carmen; Santos, Marta; Viñuela, Laura; Palacios, Rosario; Real, Luis M; Rivero, Antonio; Macías, Juan; Pineda, Juan A; García, Federico28-May-2022
Should screening for Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-men who have sex with men be recommended?Pérez-Hernández, Isabel; Palacios, Rosario; González-Doménech, Carmen; García, Victoria; Márquez, Manuel; Clavijo, Encarnación; Santos, JesúsNov-2014
Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis.Merchante, Nicolás; Rivero-Juárez, Antonio; Téllez, Francisco; Merino, Dolores; Ríos-Villegas, María J; Villalobos, Marina; Omar, Mohamed; Rincón, Pilar; Rivero, Antonio; Pérez-Pérez, Montserrat; Raffo, Miguel; López-Montesinos, Inmaculada; Palacios, Rosario; Gómez-Vidal, María A; Macías, Juan; Pineda, Juan A; Members of the HEPAVIR-Cirrhosis Study Group2018
Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals.Rivero-Juárez, Antonio; Guijo-Rubio, David; Tellez, Francisco; Palacios, Rosario; Merino, Dolores; Macías, Juan; Fernández, Juan Carlos; Gutiérrez, Pedro Antonio; Rivero, Antonio; Hervás-Martínez, César10-Jan-2020
What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis.Skaathun, Britt; Borquez, Annick; Rivero-Juarez, Antonio; Mehta, Sanjay R; Tellez, Francisco; Castaño-Carracedo, Manuel; Merino, Dolores; Palacios, Rosario; Macías, Juan; Rivero, Antonio; Martin, Natasha K8-Aug-2020